WASHINGTON — From bombastic White House speeches (and tweets) to a flurry of legislation introduced by lawmakers from both parties, it has been a whirlwind three years for policy impacting the pharmaceutical industry.

To keep track of all the fast moving developments, STAT has detailed the major proposals pending before the Trump administration and in Congress that aim to lower prescription drug prices — along with those that have already been abandoned, blocked, or softened.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Thanks for the great summary of myriad of draft bills. I look forward your updates with info on the names of co-sponsors and the status of bills.

  • It really amazes me that our legislatures do not see or is it that they don’t
    want to really see where the problem of drug pricing is. Nothing regarding
    drug pricing will ever change until there are strict laws to govern the PBM’s.
    This is where the problem lies and will always be until the PBM’s are stopped
    from fleecing every American in this country. Why on earth would President
    Trump ” pull the plug” as he said on Drug Rebates? Do the PBM’s contribute
    that much money to both political parties so that every official in Washington
    looks the other way. PBM’s don’t want change in the system . It seems to me that’s exactly what they got. Why would they want change when they’re showing 60 BILLION dollars in profit every quarter !!!!